ZANTE GREG bought VKTX
July 28, 2026 · Form 4 insider transaction
ZANTE GREG bought 31,667 shares of Viking Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
31,667
Price
$0.00
Total value
N/A
InsiderZANTE GREG
RoleOfficer
SecurityCommon Stock, par value $0.00001 per share
Transaction codeA: Grant or award
Transaction dateJuly 28, 2026
Filing dateJuly 29, 2026
Shares owned after233,421
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2023, 33.33% of which vested on July 28, 2026 upon the achievement of a non-financial performance goal.; Includes 11,055 shares acquired on May 20, 2024 pursuant to the Issuer's 2014 Employee Stock Purchase Plan and 808 shares acquired on May 20, 2026 pursuant to the Issuer's 2024 Employee Stock Purchase Plan